Jun 11, 2008
BOSTON, MA June 11, 2008 – Dr. Hiran Fernando and Dr. Damian Dupuy led a Hands-On Thoracic Course at the International Society for Minimally Invasive Cardiothoracic Surgery (ISMICS) which focused on radiofrequency ablation and how SPiN IR™ navigation enables more precise and efficient therapy delivery. Veran’s SPiN IR™ System was used in the course to demonstrate how ablation needles can be navigated into the center of cancer lesions seen on patient CT scans. “ISMICS offered Veran a great opportunity to introduce thoracic surgeons to a minimally invasive approach for the treatment of disease in the chest,” said Jerome R. Edwards, Veran President and CEO of Veran Medical Technologies. “Minimally invasive surgery and technology resonate with this group, they are eager to integrate new technology such as SPiN IR™ System into their practices.” “It is obvious in minimally invasive approaches that electromagnetic navigation is beneficial to the efficient and efficacious delivery of ablation therapy,” said Dr. Hiran Fernando, Boston University Medical Center. “Veran’s Plug-n-Play capability is key to make this an easy to use technology that allows the physician to totally focus on the therapy that he needs to deliver.”
Veran is a privately held medical device company headquartered in St. Louis, MO. The company’s mission is to empower physicians to diagnose cancer earlier and to enable precision therapy to save lives. In the United States, lung cancer kills more people each year than breast, prostate, pancreatic and colon cancers combined.
Veran has developed and commercialized an FDA cleared, next generation electromagnetic thoracic navigation platform called the SPiN Thoracic Navigation System™. Veran’s breakthrough technology has been adopted by leading cancer centers throughout the United States. Veran provides physicians with a full line of bronchoscopic brushes, needles, forceps and steerable catheters with tiny electromagnetic sensors embedded in the tips for precise navigation. The combination of these proprietary Always-On Tip Tracked® instruments and Veran’s exclusive patient respiratory gating technology enables physicians to accurately access lung nodules by accounting for nodule movement during patient breathing, a common challenge for lung specialists.
Another challenge lung specialists face is that approximately 40% of lung nodules lie outside of an airway, making them very difficult to reach endobronchially, and traditionally requiring an additional procedure. Veran’s SPiN Thoracic Navigation System™ is the first and only FDA cleared technology that enables Pulmonologists or Thoracic Surgeons to safely and accurately access lung nodules outside of an airway using SPiN Perc™, a navigated transthoracic needle. With SPiN Perc™, Veran combines endobronchial navigation with percutaneous navigation, allowing physicians to access all lung nodules in a single procedure, regardless of nodule size or location. This eliminates the cost and risk of unnecessary procedures and empowers physicians to provide a same day diagnosis for their patients. The early diagnosis and treatment of lung cancer has been proven to save lives.
Media Inquiries: Please Contact TJ Meyer at email@example.com